New Delhi: The two big giants in the philanthropic work and vaccine development respectively, have come together to create innovative solutions for public health in India. Tata Trusts and PATH on 16th January announced the establishment of the Tata Trusts-PATH Impact Lab, the first such in India, to support and bring to market innovations for affordable public health solutions to benefit vulnerable populations with limited resources.
Among the priorities will be solutions in maternal and child health, nutrition, and diagnostics for chronic and infectious diseases.
The Impact Lab’s aim is to create and sustain an ecosystem that fosters innovation in public health and provide comprehensive support to selected innovators through product design, clinical validation, commercialization and market development to help scale high quality and affordable public health innovation products that have gone beyond the prototype stage. This support will include, amongst others, infrastructure for product development through a high end ‘tinkering shop’ located at the Indian Institute of Technology-Delhi, mentorship for market access and commercialisation, and launch and scale-up strategies.
PATH has worked in India since 1978, improving health and saving lives through creativity and collaboration with local partners.